Bemotrizinol's Approval Prompts Five Questions Patients Will Ask
FDA approval of bemotrizinol sends dermatology clinics a wave of patient questions. AJMC lays out five clinicians should be ready to answer.
Topic
FDA Approval
Topic
FDA Approval
Remibrutinib Becomes First On-Label Therapy for Symptomatic Dermographism
Remibrutinib, an oral BTK inhibitor, is the first on-label therapy for symptomatic dermographism. David Cotter, MD, PhD, explains…
FDA Clears J&J Oral Psoriasis Pill to Challenge Tremfya, Skyrizi
FDA approves J&J's oral psoriasis pill, setting up a direct challenge to injectable rivals Tremfya and Skyrizi and reshaping syst…
FDA Clears First-of-its-Kind Oral Psoriasis Therapy from J&J
Johnson & Johnson has won approval for a first-of-its-kind psoriasis pill, a regulatory decision that adds a novel oral optio…
FDA Approves Pritelivir for Refractory Mucocutaneous HSV
The FDA has approved pritelivir for refractory mucocutaneous HSV in immunocompromised adults, adding a new antiviral option for a…
New Sunscreen Ingredient Reaches U.S. Shelves After FDA Greenlight
A new sunscreen ingredient now appears on U.S. shelves after the FDA cleared it for OTC sale, per News Talk 550 KFYI — but the ac…
FDA Greenlights New Sunscreen Active; Dermatologists Await Full Data
Sparse details have emerged since the FDA cleared a new sunscreen active, 1310 WIBA reported. Clinicians await the molecule, conc…
FDA Clears New Sunscreen Ingredient; Product Now on U.S. Shelves
The FDA has approved a new sunscreen ingredient and products containing it are already on U.S. retail shelves, per a WSPD report…
FDA Clears New Sunscreen Ingredient; Product Reaches U.S. Shelves
A new sunscreen ingredient has hit U.S. shelves after FDA approval, giving dermatologists a fresh photoprotection option to discu…
FDA Clears New Sunscreen Ingredient; Products Now on U.S. Shelves
The FDA has approved a new sunscreen ingredient, and products containing it are already reaching U.S. store shelves — a rare even…